BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33960364)

  • 1. Integrated analysis of ceRNA network and tumor-infiltrating immune cells in esophageal cancer.
    Chen Y; Zhou H; Wang Z; Huang Z; Wang J; Zheng M; Ni X; Liu L
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33960364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
    Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
    Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Analysis of lncRNA, miRNA and mRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer.
    Liu H; Zhang Q; Lou Q; Zhang X; Cui Y; Wang P; Yang F; Wu F; Wang J; Fan T; Li S
    Pathol Oncol Res; 2020 Apr; 26(2):1029-1039. PubMed ID: 30972633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone.
    Liu S; Song A; Zhou X; Huo Z; Yao S; Yang B; Liu Y; Wang Y
    J Bone Oncol; 2020 Oct; 24():100304. PubMed ID: 32760644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
    Yang CZ; Hu LH; Huang ZY; Deng L; Guo W; Liu S; Xiao X; Yang HX; Lin JT; Sun LL; Lin LZ
    PLoS One; 2021; 16(12):e0260720. PubMed ID: 34855841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.
    Wang L; Wei Q; Zhang M; Chen L; Li Z; Zhou C; He M; Wei M; Zhao L
    Int Immunopharmacol; 2020 Oct; 87():106795. PubMed ID: 32707495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and Analysis of a Prognostic Model of Autophagy-Related lncRNAs in ESCA.
    Chen F; Zhang J; Bai W
    Biomed Res Int; 2022; 2022():9265088. PubMed ID: 35928921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.
    Tang H; Wang Z; Shao Q; Wang Y; Yang Q
    Med Sci Monit; 2020 Jun; 26():e922676. PubMed ID: 32533823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of competitive endogenous RNA associated with immune infiltration in lung adenocarcinoma.
    Chen W; Li W; Liu Z; Ma G; Deng Y; Li X; Wang Z; Zhou Q
    Sci Rep; 2021 May; 11(1):11056. PubMed ID: 34040139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma.
    Zhang Y; Dai J; Huang W; Chen Q; Chen W; He Q; Chen F; Zhang P
    Aging (Albany NY); 2021 Dec; 13(24):25980-26002. PubMed ID: 34958632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
    Bai Y; Long J; Liu Z; Lin J; Huang H; Wang D; Yang X; Miao F; Mao Y; Sang X; Zhao H
    J Cell Physiol; 2019 Aug; 234(10):18837-18848. PubMed ID: 30916406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis.
    Huang R; Wu J; Zheng Z; Wang G; Song D; Yan P; Yin H; Hu P; Zhu X; Wang H; Lv Q; Meng T; Huang Z; Zhang J
    Front Bioeng Biotechnol; 2019; 7():257. PubMed ID: 31681739
    [No Abstract]   [Full Text] [Related]  

  • 19. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.